PathomIQ
Pathomiq is revolutionizing drug development and personalized medicine through its AI-powered platform, built upon a unique phenotype atlas. This atlas learns high-level information from vast cancer pathology data, enabling rapid deployment for use cases like predicting patient outcomes, treatment responses, and identifying genotypes. Their platform offers advantages in clinical trial acceleration, biomarker discovery, and precision cancer grading. Specifically, PATHOMIQ_PRAD analyzes H&E-stained prostatectomy images to assess biochemical relapse and metastasis risk, outperforming current genomic tools. Pathomiq's approach is non-destructive, fast, and enables deeper molecular analysis for personalized therapies.
PathomIQ
Pathomiq is revolutionizing drug development and personalized medicine through its AI-powered platform, built upon a unique phenotype atlas. This atlas learns high-level information from vast cancer pathology data, enabling rapid deployment for use cases like predicting patient outcomes, treatment responses, and identifying genotypes. Their platform offers advantages in clinical trial acceleration, biomarker discovery, and precision cancer grading. Specifically, PATHOMIQ_PRAD analyzes H&E-stained prostatectomy images to assess biochemical relapse and metastasis risk, outperforming current genomic tools. Pathomiq's approach is non-destructive, fast, and enables deeper molecular analysis for personalized therapies.